Literature DB >> 9110981

Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.

N Haneji1, T Nakamura, K Takio, K Yanagi, H Higashiyama, I Saito, S Noji, H Sugino, Y Hayashi.   

Abstract

It is unclear whether organ-specific autoantigens are critical for the development of primary Sjögren's syndrome (SS). A 120-kilodalton organ-specific autoantigen was purified from salivary gland tissues of an NFS/sld mouse model of human SS. The amino-terminal residues were identical to those of the human cytoskeletal protein alpha-fodrin. The purified antigen induced proliferative T cell responses and production of interleukin-2 and interferon-gamma in vitro. Neonatal immunization with the 120-kilodalton antigen prevented the disease in mice. Sera from patients with SS reacted positively with purified antigen and recombinant human alpha-fodrin protein, whereas those from patients with systemic lupus erythematosus and rheumatoid arthritis did not. Thus, the immune response to 120-kilodalton alpha-fodrin could be important in the initial development of primary SS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9110981     DOI: 10.1126/science.276.5312.604

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  89 in total

Review 1.  The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome.

Authors:  M G Humphreys-Beher; A B Peck; H Dang; N Talal
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.

Authors:  N Ishimaru; T Yoneda; K Saegusa; K Yanagi; N Haneji; K Moriyama; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

3.  Role of stromal-cell derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice.

Authors:  Khairul Matin; M Abdus Salam; Joynab Akhter; Nobuhiro Hanada; Hidenobu Senpuku
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

Review 4.  Immunopathogenesis of Sjögren's syndrome.

Authors:  Andrea T Borchers; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

5.  Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.

Authors:  D Zoukhri; C L Kublin
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

Review 6.  Autoimmune related pancreatitis.

Authors:  K Okazaki; T Chiba
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

7.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren's syndrome.

Authors:  Peter Szodoray; Katalin Koczok; Antonia Szanto; Ildiko Fanny Horvath; Britt Nakken; Ildiko Molnar; Margit Zeher
Journal:  Clin Rheumatol       Date:  2007-08-23       Impact factor: 2.980

9.  IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.

Authors:  Cuong Q Nguyen; Jue-hua Gao; Hyuna Kim; Daniel R Saban; Janet G Cornelius; Ammon B Peck
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 10.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.